vitamin D2/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases HDL cholesterol
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“In the D2 group there were small, but statistically significant, decreases from baseline relative to placebo in total cholesterol and ApoB (favouring D2), as well as in HDL cholesterol and ApoA1 (favouring placebo; Figure 4A).”
Quoted verbatim from Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial.. - Study
- RCT
- Duration
- 4 months
- Dose
- 100,000 IU ergocalciferol (vitamin D2) orally once monthly for 4 months
- Population
- Adults aged 30-75 at elevated risk of type 2 diabetes (non-diabetic hyperglycaemia or positive diabetes risk score), UK; vitamin D2 arm versus placebo arm
Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial.2016PMID:26700109Industry fundedPermalink
Keep reading
- Everything the graph holds on vitamin D2
- Every compound studied against HDL cholesterol
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PJNAWDKT36FPV9QZDERZV7